Japan Tobacco Corporation Reports Strong Financial Growth in Q2 2024

Aug.02.2024
Japan Tobacco Corporation Reports Strong Financial Growth in Q2 2024
Japan Tobacco Inc. (JT) reported a significant financial growth in Q2 2024, with operating income up 14%.

On August 2nd, Japan Tobacco Inc. (JT) released its financial report for the second quarter and first half of 2024, showing significant financial growth for the company in the quarter. In the second quarter, operating income increased by 14% year-on-year to 829.6 billion yen (approximately 55.8 billion USD); net profit also increased by 3.9% year-on-year to 147.9 billion yen (approximately 1 billion USD). For the first six months of the year, operating income increased by 12.7% compared to the same period in 2023, reaching 15,699 billion yen (approximately 106 billion USD); net profit increased by 6.3% year-on-year to 305.2 billion yen (approximately 20.5 billion USD).

Japan Tobacco Corporation Reports Strong Financial Growth in Q2 2024
Financial report for the second quarter and first half of 2024 | Source: JT


Key Financial Highlights for JT in the Second Quarter of 2024 (compared to the second quarter of 2023):


Total revenue increased by 14.0% to reach 829.6 billion yen. Core revenue (calculated at a constant exchange rate) grew by 6.7% to reach 745.7 billion yen. Adjusted operating profit (calculated at a constant exchange rate) increased by 2.0% to reach 223.8 billion yen. Operating profit increased by 4.7% to reach 216.8 billion yen. Net profit increased by 3.9% to reach 147.9 billion yen. Key financial highlights for the first half of 2024 for JT (compared to the first half of 2023) include:


Overall revenue increased by 12.7% to 156.99 billion yen. Core revenue, calculated at constant exchange rates, grew by 6.2% to 142.24 billion yen. Adjusted operating profit, also calculated at constant exchange rates, increased by 2.7% to 45.48 billion yen. Operating profit grew by 4.6% to 43.27 billion yen. Net profit increased by 6.3% to 30.52 billion yen.


Forecast adjustment for the full year 2024:


Income is expected to increase by 930 billion yen, with a full year growth of 9.4%. Core income (calculated at a constant exchange rate) is expected to increase by 200 billion yen, with a full year growth of 4.7%. Adjusted operating profit (calculated at a constant exchange rate) is expected to increase by 170 billion yen, with a full year growth of 2.3%. Operating profit is expected to increase by 120 billion yen, but decrease by 1.8% year-on-year. Net profit is expected to increase by 200 billion yen, but decrease by 1.5% year-on-year. Free cash flow is expected to decrease by 677 billion yen. Masamichi Terabatake, President and CEO of the JT Group, stated:


JT Group performed well in the first half of the year, with strengthened market share and pricing strategies driving growth in the tobacco business. Total sales volume increased by 2.0% year-on-year, with combustible products growing by 1.7% and HNB products (RRP) growing by 25.5%. Particularly in the Japanese market, Ploom sales increased by 36% and expanded in 21 markets globally, with sales steadily rising.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Issues Draft PMTA Guidance for Flavored E-Cigarettes, Maintaining Higher Evidence Bar for Fruit and Sweet Flavors
FDA Issues Draft PMTA Guidance for Flavored E-Cigarettes, Maintaining Higher Evidence Bar for Fruit and Sweet Flavors
The U.S. Food and Drug Administration (FDA) on March 9 released a draft guidance outlining its current thinking on premarket tobacco product applications (PMTAs) for flavored electronic nicotine delivery systems (ENDS). The document reiterates that fruit, candy, dessert, and other sweet-flavored e-cigarettes present a “significant public health risk” to youth and therefore face a higher evidentiary burden if manufacturers seek marketing authorization.
Mar.10 by 2FIRSTS.ai
Kazakhstan Investigates Social-Media Vape Sales Linked to a Banking “Drop” Arrangement
Kazakhstan Investigates Social-Media Vape Sales Linked to a Banking “Drop” Arrangement
Kazakhstan’s Financial Monitoring Agency (AFM) in Ulytau Region is conducting a pre-trial investigation into alleged illegal vape sales and the unlawful acquisition of access to a bank account. Authorities say a Satpayev resident has sold banned devices via social media since 2024 and used a “dropper” arrangement to disguise proceeds.
Jan.27 by 2FIRSTS.ai
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
During the FDA PMTA roundtable session on “Studies of Adult Benefit,” officials said flavored ENDS must demonstrate “added benefit” over tobacco-flavored products under the APPH standard, including sustained complete switching evidence. Small manufacturers questioned switching benchmarks, study duration, and bridging expectations.
Feb.11
Product | VOZOL’s New E-Cigarette Appears on Middle East Social Media, Touted at 40,000 Puffs with Dual Mesh Coils and Dual Modes
Product | VOZOL’s New E-Cigarette Appears on Middle East Social Media, Touted at 40,000 Puffs with Dual Mesh Coils and Dual Modes
VOZOL has recently promoted its MAGIC FLEX 40000 e-cigarette on its official Iraq social media account, using mainly Arabic-language posts and listing Baghdad as the account location. The campaign highlights a detachable/separate battery, the ability to switch flavors at will, ECO/POWER dual-mode operation, and a display-based user interface.
Jan.27 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
South Korea online purchasing fuels spread among younger groups; online drug cases share climbs
South Korea online purchasing fuels spread among younger groups; online drug cases share climbs
Police said detections of new drugs disguised as e-cigarettes reached 1,206 cases through September last year, up from 941 in 2022, and the number of detected drug types increased from 26 to 33 over the same period.
Feb.11 by 2FIRSTS.ai